{"url":"https://newsforagent.com/news/2026-11-07/temple-wearable-doctor-scrutiny","markdown_url":"https://newsforagent.com/news/2026-11-07/temple-wearable-doctor-scrutiny.md","title":"Temple's $30 Million Wearable Draws Doctor Scrutiny","headline":"Deepinder Goyal Defends $30 Million Temple Wearable as Doctors Question Its Science","description":"Deepinder Goyal says Temple cost $30 million to build and cites preprint correlations near 0.8 and 0.93.","section":"Incidents","published_at":"2026-11-07T05:07:05+00:00","modified_at":"2026-11-07T05:07:05+00:00","author":"News Desk","key_takeaways":["Deepinder Goyal said Temple cost $30 million to develop, including $20 million of his own money.","A medRxiv preprint comparing Temple with transcranial Doppler in 23 healthy adults reported correlations of approximately 0.8.","Temple claims a 0.93 correlation with metabolic-cart readings across more than 100 exercise sessions.","Goyal announced plans for a screenless, microphone-free AI companion on November 6."],"companies":[{"name":"Temple","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00stvo1/temple","website":"https://www.temple.com"}],"source":{"publisher":"Fortune India","title":"Deepinder Goyal’s Temple controversy: What the science says, why doctors are questioning it, and what’s next","url":"https://www.fortuneindia.com/technology/deepinder-goyals-temple-controversy-what-the-science-says-why-doctors-are-questioning-it-and-whats-next/169372"},"other_sources":[],"tags":["Incidents","Temple"],"body_markdown":"Deepinder Goyal said his head-worn [Temple](https://akta.pro/company-profiles/00stvo1/temple) device cost $30 million to develop, including $20 million of his own money, as neurologists questioned whether its readings measure what the company claims. [Fortune India](https://www.fortuneindia.com/technology/deepinder-goyals-temple-controversy-what-the-science-says-why-doctors-are-questioning-it-and-whats-next/169372) reported the figure from Goyal's November 5 statement, in which he also cited a 14-day return policy.\n\n## Goyal's Defense And The Preprint Studies\n\nTemple is a pre-revenue wearable startup founded by Goyal in 2024 and based in New Delhi that reads a proprietary \"Entropy\" biomarker from the superficial temporal artery, according to [company records](https://akta.pro/company-data). Goyal compared Temple's approach with WHOOP, arguing that wearable companies can launch before publishing validation studies.\n\nTwo BrainFlow studies have been published as preprints, meaning they have not completed formal peer review. The first, on medRxiv, compared Temple's readings with transcranial Doppler, an ultrasound technique measuring blood-flow velocity in a major brain artery, in 23 healthy adults with 20 analysed in each protocol; researchers reported correlations of approximately 0.8 and described BrainFlow as a relative index rather than a direct measurement of absolute blood flow. The second, on bioRxiv, examined 60 sessions involving 44 healthy young men against time-domain near-infrared spectroscopy; it was designed, funded and conducted by Temple, with several authors employed by the company, and its authors said further research was needed to rule out residual superficial and systemic influences.\n\nGoyal describes Entropy as a score from 1 to 250 indicating how hard the body is working to sustain itself. Temple has claimed a correlation of 0.93 with metabolic-cart readings across more than 100 exercise sessions.\n\n## What Doctors Question About The Signal\n\nNeurologist Dr Sudhir Kumar told a media organisation: \"The key questions are not whether the signal changes with exercise, stress, or meditation, but whether it reliably measures what it claims to measure, whether it adds information beyond existing metrics, and whether acting on it improves health outcomes.\" Dr Praveen Gupta, chairman of Marengo Asia International Institute of Neuro & Spine, said in a separate statement that while gravity influences circulation, \"there is no established scientific evidence that its everyday effects progressively damage the brain or cause it to age faster\".\n\n## Temple's Funding And First Device Batch\n\nTemple's $54 million friends-and-family round, also reported as a seed or initial round, drew participation from Peak XV Partners, Steadview Capital, Info Edge Ventures, Dharana Capital, Vy Capital, over 80 angel investors and more than 30 Temple employees, according to akta.pro funding records. The same records put the post-money valuation at $190 million and list a February 2026 seed of $54 million with 15 investors and a July 2026 secondary market round. Temple shipped its first 100 devices in May 2026 to an invite-only founding cohort of athletes, scientists, doctors and creators.\n\n## Pre-Orders And The AI Companion\n\nTemple's website crashed after pre-orders opened in India, and Goyal said orders work on the app but the site lacks auto-scaling, calling it a rookie mistake, The Indian Express reported. On November 6, Goyal revealed plans for a screenless, microphone-free AI companion whose motion sensors would detect vibrations from the wearer's voice for dictating messages, creating reminders and recording personal information, and he apologised for grouping all Indian doctors together, saying his criticism was directed at a few individuals he described as influencers.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}